Innovative Medicines Initiative - IMI 2, upcoming calls

|In Evidence|10 December 2015

IMI (Innovative Medicine Initiative) 2 is the world's biggest public-private partnership (PPP) in the life sciences. Through the IMI 2 programme, it has a 3,3 billion of euros budget for the period 2014-2024.

The indicative topics under consideration for inclusion in the first call are:        

  • Validation of translational imaging methods in drug safety assessment (TRISTAN)
  • Identification of drugable targets modulating misfolded proteins in major neurodegenerative diseases
  • Pathological neuron-glia interactions in neuropathic pain
To read this content please subscribe or upgrade your Membership.